CPRX is the #1 stock in the biotech group by almost every metric. The table on the chart shows its ranking out of all 795 biotech stocks by 3 metrics from IBD's MarketSmith.

Sales and earnings are surging and the rate at which both are growing has increased in each of the last 4 quarters.

The stock made a false breakout on December 14 when the market gapped up on CPI data. It then put in a shakeout move to hit stops before rallying right out of its base.

I am taking a small position in the stock here with a tight stop at 17.65. I want to see new highs in the next several days to confirm the breakout has legs.
Beyond Technical AnalysisbreakoutbreakouttradebreakouttradingCPRXTechnical IndicatorspullbackbuyrossgivensTrend Analysis

Also on:

Disclaimer